questionText: To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the new NHS Commercial Framework allows for increased use of indication-specific pricing agreements to support patient access to future cancer innovations.
answerText: As part of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth, NHS England committed to undertake two consultations on amendments to the NHS Commercial Framework for New Medicines. The first of these launched on 31 July 2024 for ei...
heading: Cancer: Medical Treatments